The upcoming EpiPen patent expiration on 11 September 2025 sets the stage for a pivotal shift in the epinephrine delivery market.

Boehringer and Click's CT-155 plus antipsychotics significantly reduced negative symptoms associated with schizophrenia in a Phase III trial ...

Zimmer has lifted its 2025 outlook due to growth in its sports medicine, extremities, trauma, craniomaxillofacial and thoracic business.

Natera has introduced a non-invasive prenatal test (NIPT), Fetal Focus, specifically designed for inherited conditions. According to the company, when a pregnant individual is found to carry a ...

HistoSonics has announced a majority stake acquisition by a consortium involving a transaction that values the company at $2.25bn.

China's NMPA has approved Bracco Imaging's ultrasound contrast agent, sulphur hexafluoride (SF6) microbubbles.

California-based startup Apreo Health has raised $130m to further the development of its implant for treating severe emphysema.

The US Federal Trade Commission (FTC) is suing Edwards Lifesciences to stop it from acquiring JenaValve, citing anticompetitive concerns.

Freenome has entered an exclusive licence agreement with Exact Sciences, granting the latter the rights to commercialise Freenome's blood-based CRC screening test in the US.

Medical Device Network sat down with Dexcom's outgoing CEO Kevin Sayer to learn more about how the company will maintain its market position and drive innovation in the CGM space in the future.

GlobalData’s clinical trials dashboard is powered by the Medical Intelligence Center, which boasts a highly comprehensive source of Clinical Trials collated from numerous government, non-government ...

A key trend in the medical device market is smaller and smarter, which requires advanced materials and is the focus of the ...